Literature DB >> 10796001

Optimal timing for initial and redistribution technetium 99m-N-NOET image acquisition.

F D Petruzella1, M Ruiz, P Katsiyiannis, D D Watson, R Pasqualini, G A Beller, D K Glover.   

Abstract

BACKGROUND: Bis (N-ethoxy, N-ethyl dithiocarbamato) nitrido technetium-99m (V) (Tc-99m-N-NOET) is a new Tc-99m-labeled myocardial perfusion imaging agent that redistributes. We sought to determine the optimal timing for acquiring initial and delayed images to maximize sensitivity for the detection of coronary stenoses.
METHODS: Twelve anesthetized dogs with critical stenoses of the left anterior descending coronary artery were infused with adenosine (250 microg/kg/min) or MRE-0470, an adenosine A2a agonist (0.6 microg/kg/min x 10 minutes), and Tc-99m-N-NOET (8 mCi; 296 MBq) was injected intravenously at peak flow. Myocardial and lung Tc-99m-N-NOET activities were determined by serial quantitative imaging and arterial blood sampling was performed over 2 hours.
RESULTS: Left anterior descending/left circumflex artery defect count ratios showed rapid redistribution during the first 10 minutes after Tc-99m-N-NOET injection (0.66 +/- 0.02 at 2 minutes to 0.73 +/- 0.01 at 10 minutes; P < .01). Redistribution was nearly complete by 120 minutes (defect ratio = 0.87 +/- 0.03; P < or = .01 vs 2 minutes). Lung activity fell significantly during the first 10 minutes from a heart/lung activity ratio of 1.07 +/- 0.05 (2 minutes) to 1.44 +/- 0.09 (10 minutes; P < or = .01).
CONCLUSION: Initial stress Tc-99m-N-NOET images should be acquired within 10 minutes after injection, whereas delayed images can be obtained as early as 2 hours later. Lung activity clears rapidly, permitting acquisition of good-quality poststress cardiac images. These Tc-99m-N-NOET uptake and redistribution kinetics after vasodilator stress provide important information for designing clinical imaging protocols for optimal identification of inducible ischemia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10796001     DOI: 10.1016/s1071-3581(00)90032-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  22 in total

1.  Rapid radiotracer washout from the heart: effect on image quality in SPECT performed with a single-headed gamma camera system.

Authors:  M K O'Connor; D S Cho
Journal:  J Nucl Med       Date:  1992-06       Impact factor: 10.057

2.  Myocardial clearance kinetics of technetium-99m-SQ30217: a marker of regional myocardial blood flow.

Authors:  R E Stewart; M Schwaiger; G D Hutchins; P C Chiao; K P Gallagher; N Nguyen; N A Petry; W L Rogers
Journal:  J Nucl Med       Date:  1990-07       Impact factor: 10.057

3.  Diagnostic value of a new myocardial perfusion agent, teboroxime (SO 30,217), utilizing a rapid planar imaging protocol: preliminary results.

Authors:  R C Hendel; B McSherry; M Karimeddini; J A Leppo
Journal:  J Am Coll Cardiol       Date:  1990-11       Impact factor: 24.094

4.  A neutral technetium-99m complex for myocardial imaging.

Authors:  R K Narra; A D Nunn; B L Kuczynski; T Feld; P Wedeking; W C Eckelman
Journal:  J Nucl Med       Date:  1989-11       Impact factor: 10.057

5.  Myocardial uptake and redistribution of 99mTc-N-NOET in dogs with either sustained coronary low flow or transient coronary occlusion: comparison with 201Tl and myocardial blood flow.

Authors:  G Vanzetto; D A Calnon; M Ruiz; D D Watson; R Pasqualini; G A Beller; D K Glover
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

6.  Technical aspects of myocardial planar imaging with technetium-99m sestamibi.

Authors:  W H Smith; D D Watson
Journal:  Am J Cardiol       Date:  1990-10-16       Impact factor: 2.778

7.  Subcellular distribution of technetium-99m-N-NOEt in rat myocardium.

Authors:  L Uccelli; M Giganti; A Duatti; C Bolzati; R Pasqualini; C Cittanti; P Colamussi; A Piffanelli
Journal:  J Nucl Med       Date:  1995-11       Impact factor: 10.057

8.  Myocardial extraction of teboroxime: effects of teboroxime interaction with blood.

Authors:  W L Rumsey; K C Rosenspire; A D Nunn
Journal:  J Nucl Med       Date:  1992-01       Impact factor: 10.057

9.  Tomographic myocardial perfusion imaging with technetium-99m teboroxime during adenosine-induced coronary hyperemia: correlation with thallium-201 imaging.

Authors:  A S Iskandrian; J Heo; T Nguyen; S Beer; V Cave; D Cassel; B B Iskandrian
Journal:  J Am Coll Cardiol       Date:  1992-02       Impact factor: 24.094

10.  Uptake of technetium-99m-teboroxime in cultured myocardial cells: comparison with thallium-201 and technetium-99m-sestamibi.

Authors:  J C Maublant; N Moins; P Gachon; M Renoux; Z Zhang; A Veyre
Journal:  J Nucl Med       Date:  1993-02       Impact factor: 10.057

View more
  5 in total

1.  Technetium 99m-N-NOET: although not equivalent to thallium-201, it still offers new opportunities.

Authors:  A J Sinusas
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

Review 2.  Comparison of Tl-201 with Tc-99m-labeled myocardial perfusion agents: technical, physiologic, and clinical issues.

Authors:  P Kailasnath; A J Sinusas
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

Review 3.  Myocardial perfusion imaging agents: SPECT and PET.

Authors:  George A Beller; Steven R Bergmann
Journal:  J Nucl Cardiol       Date:  2004 Jan-Feb       Impact factor: 5.952

4.  Tc-99m N-NOET: Chronicle of a unique perfusion imaging agent and a missed opportunity?

Authors:  Gérald Vanzetto; Daniel Fagret; Catherine Ghezzi
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

5.  Comparison between Tc-99m N-NOET and Tl-201 in the assessment of patients with known or suspected coronary artery disease.

Authors:  Paramjit Jeetley; Nikant K Sabharwal; Prem Soman; Chris Kinsey; Usha Raval; Uday Bhonsle; Avijit Lahiri
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.